TOMASELLO, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 288
EU - Europa 254
AS - Asia 100
Totale 642
Nazione #
US - Stati Uniti d'America 286
IE - Irlanda 83
CN - Cina 79
SE - Svezia 76
IT - Italia 36
FI - Finlandia 32
DE - Germania 14
SG - Singapore 11
TR - Turchia 5
BE - Belgio 3
CZ - Repubblica Ceca 3
FR - Francia 3
IN - India 3
CA - Canada 2
IR - Iran 2
RU - Federazione Russa 2
NL - Olanda 1
UA - Ucraina 1
Totale 642
Città #
Chandler 90
Dublin 83
New York 30
Shanghai 22
Ann Arbor 21
Ashburn 18
Dearborn 17
Parma 16
Princeton 13
Nanjing 11
Beijing 9
Bremen 6
Jinan 6
Boardman 5
Helsinki 5
Izmir 5
Seattle 5
Wilmington 4
Brussels 3
Changsha 3
Hebei 3
Hefei 3
Nanchang 3
Shenyang 3
Singapore 3
Woodbridge 3
Fremont 2
Guangzhou 2
Mestre 2
Modena 2
Norwalk 2
Pune 2
Tianjin 2
Carlentini 1
Casalgrande 1
Des Moines 1
Fayetteville 1
Fuzhou 1
Haikou 1
Hangzhou 1
Henderson 1
Jiaxing 1
Lanzhou 1
Leawood 1
Ningbo 1
Ottawa 1
Redwood City 1
Rio Saliceto 1
Rockville 1
San Mateo 1
Taiyuan 1
Taizhou 1
Toronto 1
Verona 1
Vladikavkaz 1
Xian 1
Totale 427
Nome #
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 88
Notch expression and bevacizumab efficacy in colorectal cancer patients 74
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 70
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 70
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 60
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 56
Immunotherapy options in metastatic renal cell cancer: Where we are and where we are going 41
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer 40
A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer 37
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: A case report 36
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon α-2a as first-line endocrine treatments in advanced breast cancer: Updated results of a phase II, prospective, randomised multicentre trial 31
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen 30
Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: Results of a phase II trial 29
Totale 662
Categoria #
all - tutte 2.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 13 5 0 7 6 18 7 2 4 23 0 0
2020/202135 3 1 1 1 4 3 1 7 6 2 5 1
2021/202256 2 0 0 5 2 0 12 2 1 3 4 25
2022/2023283 34 42 19 17 17 32 4 16 92 0 9 1
2023/2024111 0 13 1 1 5 50 11 5 3 3 10 9
Totale 662